PBRM1 and BAP1 as novel targets for renal cell carcinoma
about
Choosing the right cell line for renal cell cancer researchThe roles of chromatin-remodelers and epigenetic modifiers in kidney cancerMolecular genetics of clear-cell renal cell carcinomaLoss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneityCharacterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevanceMetastatic clear cell renal carcinoma - an unusual response to Temsirolimus in second line therapy.Current management and future perspectives of metastatic renal cell carcinoma.Landmarks in the diagnosis and treatment of renal cell carcinoma.Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens.The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions in vivo.Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.Targeted therapies for renal cell carcinoma.Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1.Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinomaEpigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade.Identify clear cell renal cell carcinoma related genes by gene network.A germline mutation in PBRM1 predisposes to renal cell carcinoma.CD4-Negative Variant of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel PBRM1 Mutation in an 11-Year-Old Girl.Renal cell carcinoma: a review of biology and pathophysiology.EGFR amplification induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma.Personalized Integrated Network Modeling of the Cancer Proteome Atlas
P2860
Q28073283-99664DBF-8F74-4533-A4E6-A803FFD14867Q28083152-CDD658E7-F9D8-468A-8361-6D55BEC0FFB1Q33729097-3D5E7B32-0326-4DD7-9459-1FA110E9BFCBQ33821055-F08A43AA-D720-46D3-B768-50454077B6CFQ34758616-6EF514A2-CB8F-40D5-9205-63AEBCAD8320Q35590879-AB8C5B0E-2289-40A9-9862-32E7B4A82A52Q35891370-A88225EC-65D6-4B60-94F1-0981A48FB508Q36105139-C8BF867D-7F73-48C7-917A-77DA68481784Q36890998-E0C49924-D05C-43EA-8905-E708BA843971Q38214976-5EC01042-F2F6-4DBC-A0AA-8DA7B29831C7Q38238966-C58D3747-EC1C-4303-B6DD-B2114D24E220Q38794945-8EA489E0-DF7A-4DA9-8B05-532E137D28A0Q38811459-0837071F-AA07-468B-B868-FF79DAEA9D72Q39010963-85A17183-998B-4B3F-A5DB-1EE6E5461216Q39095254-3852F46E-1F18-4B4E-90FA-2CD4EB183F87Q39229171-895BF87F-3F21-474F-84D6-A96A3ECED643Q39425380-19806C27-4692-4F67-A5D4-298408E4BDE0Q40467070-EC902F2A-DA1F-4B26-AE0A-F4A2C628CEC9Q41242139-BE37DF48-01EB-4B71-A410-5B53D43C2F17Q41447434-D4744C7D-6906-4AAC-AF88-3F903A202B1DQ41574276-709A95D7-4A5A-4E58-86B1-7A20912F6FE9Q46856592-E6F56A39-022B-4EFE-8516-18C79D6AC424Q47105288-11C0FCAD-5D94-4FF5-98B7-5B9DB4E3D37EQ49092051-250F1D80-8CC2-451F-A9EE-E88AD7D6F6BDQ51051685-4DC3F31C-4DE1-42DA-BA83-70BF7E37200DQ52724797-0666E978-500A-47C5-B9D7-F8D63E0F613BQ54980217-254B424C-8FCA-43A0-9B95-7E41F4B6C229Q57296231-8BF13814-B36D-40AE-A3E1-352F8F058B4B
P2860
PBRM1 and BAP1 as novel targets for renal cell carcinoma
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
PBRM1 and BAP1 as novel targets for renal cell carcinoma
@en
type
label
PBRM1 and BAP1 as novel targets for renal cell carcinoma
@en
prefLabel
PBRM1 and BAP1 as novel targets for renal cell carcinoma
@en
P2860
P1433
P1476
PBRM1 and BAP1 as novel targets for renal cell carcinoma
@en
P2093
James Brugarolas
P2860
P304
P356
10.1097/PPO.0B013E3182A102D1
P577
2013-07-01T00:00:00Z